Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: DEXMEDETOMIDINE: Dose -0.5µg/kg
Frequency - Stat
Route of Administration- Intravenous
Total duration- 10 min
Control Intervention1: LIGNOCAINE 2%: Dose-1.5mg/k
Sponsors
ESIC MC PGIMSR and Model Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient willing to give informed consent. 2. Patients age between 18 and 60 years of either gender. 3. American society of anesthesiologists physical status (ASA) grade 1 and grade 2 patients. 4. Patients scheduled for elective laparoscopic cholecystectomy surgeries.
Exclusion criteria
Exclusion criteria: 1. Patient allergy to dexmedetomidine, Lignocaine and other alpha-2 agonists. 2. Patients on pain perception modifying drugs and beta blockers. 3. Patient with impaired mental status, Alcohol or drug abuse. 4. Pregnant patients and patients with autonomic neuropathies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of extubation will be evaluated based on 5-point rating scale immediately after extubation. The soar throat , throat irritation and breathing pattern will be better in study group in 30minTimepoint: Baseline- less cough 4weeks- No Throat pain 8weeks- No Throat Irritation | — |
Secondary
| Measure | Time frame |
|---|---|
| Better patient satisfaction and HemodynamicsTimepoint: Base line- No Bronchospasm 4weeks- No breathing difficulty 8 weeks- No cough | — |
Countries
India
Contacts
Public ContactSanthosh Kumar T N
ESIC MC PGIMSR & Model Hospital
Outcome results
None listed